NCT00512252View on ClinicalTrials.gov

AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG

AMD3100

DRUG

Mitoxantrone

DRUG

Etoposide

DRUG

Cytarabine

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00512252 - AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter